Management of Elevated Uric Acid

Introduction to Urate-Lowering Therapy (ULT)

• The European League Against Rheumatism recommends starting allopurinol 100 mg daily and titrating by 100 mg every 2-4 weeks until serum uric acid is below 6 mg/dL, maintaining this target lifelong 1, 2
• Urate-lowering therapy should be discussed with every patient who has elevated uric acid in the context of gout from first presentation 1, 2

Indications for ULT

• Absolute indications for ULT include recurrent gout flares, tophi, urate arthropathy, and renal stones 1, 2
• Strong indications for early ULT include age <40 years at presentation, serum uric acid >8.0 mg/dL, and comorbidities such as renal impairment, hypertension, ischemic heart disease, or heart failure 1, 2

Target Serum Uric Acid Levels

• The European League Against Rheumatism recommends maintaining serum uric acid <6 mg/dL lifelong for all patients on ULT 1, 2
• For patients with severe disease, target serum uric acid <5 mg/dL until complete crystal dissolution 1, 2

First-Line Pharmacologic Management

• The European League Against Rheumatism recommends starting allopurinol at 100 mg daily and increasing by 100 mg increments every 2-4 weeks until target serum uric acid is achieved 1, 2
• Allopurinol dose should be adjusted based on creatinine clearance in patients with renal impairment 1, 2

Second-Line Options

• If allopurinol fails to reach target, consider switching to febuxostat or adding a uricosuric agent such as probenecid or sulphinpyrazone 1, 2, 3
• Benzbromarone can be used in mild-to-moderate renal impairment, but carries a risk of hepatotoxicity 1, 3

Flare Prophylaxis During ULT Initiation

• All patients starting ULT require prophylaxis for the first 6 months, with colchicine 0.5-1 mg daily as first choice 1, 2
• Low-dose NSAIDs can be used as an alternative to colchicine if contraindicated or not tolerated 1, 2

Non-Pharmacologic Management

• The European League Against Rheumatism recommends comprehensive lifestyle modification, including weight loss if overweight or obese, regular physical activity, and dietary modifications 1, 2, 4
• Patients should avoid alcohol, sugar-sweetened drinks, and foods rich in fructose, and encourage low-fat dairy products, coffee, and cherries 1, 2, 4

Comorbidity Screening

• Screen all patients for associated comorbidities, including renal impairment, coronary heart disease, heart failure, stroke, peripheral arterial disease, obesity, hyperlipidemia, hypertension, and diabetes 4

Special Screening Considerations

• For patients with gout onset before age 25 or history of urolithiasis, screen for uric acid overproduction with 24-hour urine uric acid collection 5

Monitoring Strategy

• Check serum uric acid every 2-4 weeks during dose titration, and once stable, monitor regularly to ensure target maintained 1, 2
• Continue ULT indefinitely, as this is lifelong therapy 1, 2